Luminal A Breast Cancer Treated With Endocrine Therapy Before Partial Mastectomy
This breast cancer diagnosis at a glance
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- luminal A
- Sex
- Female
- Treatment
- endocrine therapy and surgery
Treatment course, step by step
- Received an aromatase inhibitor for 3 months before surgery, which made the breast lesion much smaller.
- Underwent partial mastectomy with a negative surgical margin.
What happened, in summary
A 56-year-old Japanese woman had invasive ductal carcinoma of the breast described as luminal A type. She received an aromatase inhibitor for 3 months before surgery. The treatment worked well enough that the lesion became very small and was nearly impossible to see with ultrasound.
Because the shrinking tumor was difficult to localize, the surgical team used the pattern of superficial breast veins as an additional landmark. They compared the veins seen on contrast-enhanced CT with those visualized on the skin to help predict where the treated tumor was located.
She then underwent partial mastectomy. Pathology showed a negative resection margin, meaning the removed specimen did not have tumor at the cut edge.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Endocrine Therapy for Breast Cancer 36 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer